- JP-listed companies
- Kringle Pharma,Inc.
Kringle Pharma,Inc.JP:4884
Market cap
¥4.3B
P/E ratio
Sep 30, 2018 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | Sep 30, 2023 | |
Net sales | - | - | - | - | - | 69 |
Gross profit (loss) | - | - | - | - | - | 69 |
Selling, general and administrative expenses | - | - | - | - | - | 958 |
Operating profit (loss) | - | - | - | - | - | -889 |
Interest income | - | - | - | - | - | 0 |
Subsidy income | - | - | - | - | - | 43 |
Foreign exchange gains | - | - | - | - | - | 0 |
Interest on tax refund | - | - | - | - | - | 0 |
Other | - | - | - | - | - | - |
Non-operating income | - | - | - | - | - | 43 |
Share acquisition rights issuance costs | - | - | - | - | - | 7 |
Non-operating expenses | - | - | - | - | - | 7 |
Ordinary profit (loss) | - | - | - | - | - | -853 |
Profit (loss) before income taxes | - | - | - | - | - | -853 |
Income taxes - current | - | - | - | - | - | 1 |
Income taxes | - | - | - | - | - | 1 |
Profit (loss) | - | - | - | - | - | -854 |